Myocardial angiotensin receptor type 1 gene expression in a rat model of cardiac volume overload

被引：0

作者：

Bauer P. ^{[1
]}

Regitz-Zagrosek V. ^{[1
]}

Kallisch H. ^{[1
]}

Linz W. ^{[2
]}

Schoelkens B. ^{[2
]}

Hildebrandt A.G. ^{[3
]}

Fleck E. ^{[1
]}

机构：

[1] Deutsches Herzzentrum, 13353 Berlin

[2] Hoechst AG

[3] Bundesinstitut für Arzneimittel, 13353 Berlin

来源：

Basic Research in Cardiology | 1997年 / 92卷 / 3期

关键词：

Angiotensin receptor; Aortocaval shunt; Heart failure; mRNA;

D O I：

10.1007/BF00788631

中图分类号：

学科分类号：

摘要：

To investigate the regulation of the angiotensin receptor type 1 (AT1) in different organs in cardiac volume overload, we measured AT1 mRNA content in the atria, left and right ventricle, kidney and liver of rats with an aortocaval shunt, produced by infrarenal aortocaval puncture 4 weeks earlier. For angiotensin receptor mRNA quantitation a novel quantitative PCR procedure based on liquid phase hybridization was used that allowed the determination of absolute AT1 mRNA copy numbers and its comparison in different organs. Glyceraldehydephosphate dehydrogenase (GAPDH) mRNA was measured by RT-PCR to control externally equal mRNA content and quality of RNA extraction in shunt animals and controls. Heart weight was increased in the shunt animals, with the greatest increase in the atria. Blood pressure, plasma renin activity, plasma angiotensin I and II and aldosterone concentrations were not significantly altered. The AT1 mRNA content was significantly increased in the atria (shunt: 1167 ± 350 copies AT1 mRNA/ng RNA vs controls: 803 ± 240; p < 0.05). No change was found in the right or left ventricle, in the kidney and liver. The findings document that atrial hypertrophy in cardiac volume overload parallel with a significant increase in atrial AT1 mRNA content.

引用

页码：139 / 146

页数：7

共 25 条

[1]

Aceto J.F., Baker K.M., [Sar<sup>1</sup>]angiotensin II receptor-mediated stimulation of protein synthesis and cell growth in chick heart cells, Am J Physiol, 259, (1990)

[2]

Bauer P., Regitz-Zagrosek V., Hofmeister J., Lokies J., Rolfs A., Hildehrandt A.G., Hetzer R., Fleck E., Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure: Assessment by a novel quantitative PCR-ELISA technique, J Mol Med, 74, pp. 447-454, (1996)

[3]

Bauer P., Rolfs A., Regitz-Zagrosek V., Hildebrandt A., Fleck E., Use of Mn<sup>2+</sup> in RT-PCR eliminates PCR artifacts resulting from DNase I digestion, BioTechniques, JULY ISSUE, (1997)

[4]

Calderone A., Takahashi N., Izzo N.J., Thaik C.M., Colucci W.S., Pressure-and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs, Circulation, 92, pp. 2385-2390, (1995)

[5]

Dostal D.E., Baker K.M., Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart, Am J Hypertens, 5, pp. 276-280, (1992)

[6]

Fielitz J., Regitz-Zagrosek V., Bauer P., Lokies J., Fleck E., Ein Verlust an Angiotensinrezeptor Subtyp 1 (ATI) mRNA ist bei Herzinsuffizienz in rechtsventrikulären Endomyokardbiopsien nachweisbar, Z Kardiol, 85, 1 SUPPL., (1996)

[7]

Friedrich S.P., Lorell B.H., Rousseau M.F., Hayashida W., Hess O.M., Douglas P.S., Gordon S., Keighley C.S., Benedict C., Krayenbuhl H.P., Grossman W., Pouleur H., Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy, Circulation, 90, pp. 2761-2771, (1994)

[8]

Garcia R., Diebold S., Simple, rapid, and effective method of producing aortocaval shunts in the rat, Cardiovasc Res, 24, pp. 430-432, (1990)

[9]

Haber H.L., Powers E.R., Gimple L.W., Clarence C.W., Subbiah K., Johnson W.H., Feldman M.D., Intracoronary angiotensin-converting enzyme inhibition improves distolic function in patients with hypertensive left ventricular hypertrophy, Circulation, 89, pp. 2616-2625, (1994)

[10]

Hein L., Stevens M.E., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K., Cardiac remodelling in transgenic mice expressing angiotensin AT1a receptors under control of the myosin heavy chain promoter, Circulation, 92, ABSTR SUPPL., pp. 1-63, (1995)

← 1 2 3 →